A novel FAPα-based Z-Gly-Pro epirubicin prodrug for improving tumor-targeting chemotherapy
- 1 November 2017
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 815, 166-172
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functionsClinical & Experimental Metastasis, 2011
- Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxinMolecular Cancer Therapeutics, 2009
- Safety, Pharmacokinetics and Biodistribution Studies of a β-galactoside Prodrug of Doxorubicin for Improvement of Tumor Selective ChemotherapyDrug Development and Industrial Pharmacy, 2008
- Albumin-Binding Prodrugs of Camptothecin and Doxorubicin with an Ala-Leu-Ala-Leu-Linker That Are Cleaved by Cathepsin B: Synthesis and Antitumor EfficacyBioconjugate Chemistry, 2007
- Structural and Kinetic Analysis of the Substrate Specificity of Human Fibroblast Activation Protein αJournal of Biological Chemistry, 2005
- A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapyBiochemical Pharmacology, 2004
- Enzyme-Catalyzed Activation of Anticancer ProdrugsPharmacological Reviews, 2004
- Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breastInternational Journal of Cancer, 2001
- Prodrugs of Anthracyclines for Use in Antibody-Directed Enzyme Prodrug TherapyJournal of Medicinal Chemistry, 1998
- Intensely Cytotoxic Anthracycline Prodrugs: GlucuronidesJournal of Medicinal Chemistry, 1997